| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(20000120)89:1<92::AID-IJC15>3.0.CO;2-8 |
| P698 | PubMed publication ID | 10719737 |
| P50 | author | Noriaki Sakuragi | Q67487481 |
| P2093 | author name string | M Tada | |
| M Takahashi | |||
| Y Sato | |||
| Y Fujioka | |||
| H Takahashi | |||
| S Todo | |||
| T Moriuchi | |||
| H Tonoki | |||
| J Hamada | |||
| H Kashiwazaki | |||
| K Furuuchi | |||
| P2860 | cites work | Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells | Q41070371 |
| Multistep carcinogenesis of breast cancer and tumour heterogeneity | Q41540149 | ||
| High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay | Q43601202 | ||
| Mutations in the estrogen receptor gene | Q54188019 | ||
| Increased expression of mutant forms of p53 oncogene in primary lung cancer | Q58212568 | ||
| Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy | Q71563602 | ||
| p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment | Q72359939 | ||
| Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells | Q74292334 | ||
| Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women | Q77889724 | ||
| Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
| The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 | Q28266637 | ||
| Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction | Q29618515 | ||
| IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools | Q30429006 | ||
| Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas | Q34053843 | ||
| A simple p53 functional assay for screening cell lines, blood, and tumors | Q34397902 | ||
| Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies | Q34400583 | ||
| Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma | Q35807817 | ||
| Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group | Q35978157 | ||
| Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle | Q36216944 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 92-99 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers | |
| P478 | volume | 89 |
| Q44355315 | A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines |
| Q34570100 | Assessing TP53 status in human tumours to evaluate clinical outcome |
| Q44707549 | Chromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutations |
| Q44524738 | High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. |
| Q36308536 | P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection |
| Q33739357 | Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q40106083 | p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells |
Search more.